Day: October 28, 2025

Steven Bartlett raises eight-figure round for Steven.com at €365M valuation

Steven Bartlett raises eight-figure round for Steven.com at €365M valuation Entrepreneur, investor and Dragons’ Den star Steven Bartlett has raised an eight-figure funding round for his media and technology company Steven.com, valuing the business at €365 million. The round, led by Slow Ventures and Apeiron Investment Group, is believed to

Sequoia launches two early-stage funds, says Europe’s founder pool “never been stronger”

Sequoia launches two early-stage funds, says Europe’s founder pool “never been stronger” Sequoia, the US VC firm which has backed Klarna and Stripe, has launched two early-stage funds and given a vote of confidence to European founders. The two new funds are a $750 million early-stage fund targeting Series A startups

Adaptam Therapeutics raises €3M to advance cancer immunotherapies

Adaptam Therapeutics raises €3M to advance cancer immunotherapies San Sebastián and Barcelona-based biotech Adaptam Therapeutics has raised €3 million in a pre-seed round led by Criteria Bio Ventures to develop first-in-class antibody therapies targeting immunosuppressive myeloid cells in solid tumours. The funding will allow Adaptam to advance its antibody-based programmes,

When high school meets high tech: ReSeed’s mission to reforest fire-affected Greece

When high school meets high tech: ReSeed’s mission to reforest fire-affected Greece Every summer, forests around the world are destroyed by fires. Traditionally, reseeding is labour-intensive, slow, and often limited in access due to steep slopes and the remote nature of fire-affected zones.   But now a not-for-profit startup spun out

BMLL acquired by Nordic Capital

BMLL acquired by Nordic Capital UK’s BMLL is set to be acquired by Nordic Capital in a transaction carried out with BMLL’s management and minority shareholder Optiver. Financial terms were not disclosed. BMLL is an independent provider of harmonised historical market data and analytics, delivering Level 3, Level 2, and

From Dragons’ Den to Disney ambitions: Steven Bartlett raises eight-figure round for Steven.com

From Dragons’ Den to Disney ambitions: Steven Bartlett raises eight-figure round for Steven.com Podcast personality and entrepreneur Steven Bartlett today announced his company Steven.com has closed a major eight-figure investment, at a €365 million valuation to build what he calls the “Disney of the creator economy” and take his growing

With Series A extended to €30 million, France’s Dracula Technologies accelerates rollout of ambient-light energy solutions

With Series A extended to €30 million, France’s Dracula Technologies accelerates rollout of ambient-light energy solutions Valence-based Dracula Technologies, a pioneer in enabling battery-free IoT through energy harvesting from ambient indoor light, announced the completion of its Series A extension round, bringing the total Series A funding to €30 million. The

Spain’s Adaptam Therapeutics secures €3 million to target immune cells that help tumours evade treatment

Spain’s Adaptam Therapeutics secures €3 million to target immune cells that help tumours evade treatment Adaptam Therapeutics, a San Sebastian-based company pioneering cancer immunotherapies specifically targeting immunosuppressive myeloid cells, today announces the successful completion of a €3 million pre-Seed financing round The round was led by Criteria Bio Ventures and

€10.3 million boost for Sweden’s Cellcolabs to lower global stem cell costs by 90% through scalable manufacturing

€10.3 million boost for Sweden’s Cellcolabs to lower global stem cell costs by 90% through scalable manufacturing Cellcolabs, a Stockholm-based BioTech startup focused on industrial-scale production of mesenchymal stem cells (MSCs), has secured €10.3 million in new funding to support further technical development, production scaling, and global market expansion. The investment

Sweden’s Lithea secures €851k to advance tumour-targeted therapy for childhood bone cancer

Sweden’s Lithea secures €851k to advance tumour-targeted therapy for childhood bone cancer Lithea, a Lund-based company working on new ways to treat cancer by delivering medicine directly into tumours, has successfully raised €851k from its current investors to continue developing their drug delivery system and prepare its lead product, LIT1001,